Analgesia and serum assays of controlled-release dihydrocodeine and metabolites in cancer patients with pain

Pharmacological Reports

Volumn 64, Issue 1, 2012, Pages 84-93

  Leppert, Wojciech ^a   Mikołajczak, Przemysław ^a,b   Kamińska, Ewa ^a   Szulc, Michał ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF NATURAL FIBRES AND MEDICINAL PLANTS   (Poland)

Author keywords

Analgesia; Cancer pain; Dihydrocodeine; Opioid; Treatment

Indexed keywords

CODEINE 6 GLUCURONIDE; DIHYDROCODEINE; DIHYDROCODEINE 6 GLUCURONIDE; DRUG METABOLITE; HYDROMORPHONE; METOCLOPRAMIDE; NORDIHYDROMORPHONE; TRAMADOL; UNCLASSIFIED DRUG;

ADULT; AGED; ANALGESIA; ARTICLE; BRIEF PAIN INVENTORY; CANCER PAIN; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE TITRATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NOCICEPTIVE PAIN; PAIN ASSESSMENT; QUALITY OF LIFE; TREND STUDY; VISUAL ANALOG SCALE;

EID: 84862202244     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(12)70734-X     Document Type: Article

References (28)

1. Ammon S, Hofmann U, Griese EU, Gugeler N, Mikus G: Pharmacokinetics of dihydrocodeine and its active metabolite after single and multiple oral dosing. Br J Clin Pharmacol, 1999, 48, 317-322. (Pubitemid 29417713)
2. Balikova M, Maresova V, Habrdova V: Evaluation of urinary dihydrocodeine excretion in human by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl, 2001, 752, 179-186. (Pubitemid 32141207)
3. Dobrogowski J, Hilgier M: Clinical trial of DHC continous tablets in the treatment of chronic pain (Polish). Współcz Onkol, 2003, 7, 528-534.
4. Fromm MF, Hofmann U, Griese EU, Mikus G: Dihydrocodeine: A new opioid substrate for the polymorphic CYP2D6 in humans. Clin Pharmacol Ther, 1995, 58, 374-382.
5. Gasche Y, Daali Y, Fathi M, Chiappe A, Cottini S, Dayer P, Desmeules J: Codeine intoxication associated with ultrarapid CYP2D6 metabolism. N Engl J Med, 2004, 351, 2827-2831. (Pubitemid 40051906)
6. Gravenstein JS, Smith GM, Sphire RD, Isaacs JP, Beecher HK: Dihydrocodeine. N Engl J Med, 1956, 254, 877-885.
7. Jurna I, Kömen W, Baldauf J, Fleischer W: Analgesia by dihydrocodeine is not due to formation of dihydromorphine: evidence from nociceptive activity in rat thalamus. J Pharmacol Exp Ther, 1997, 281, 1164-1170. (Pubitemid 27258373)
8. Keats AS, Telford J, Kurosu Y: Studies of analgesic drugs: dihydrocodeine. J Pharmacol Exp Ther, 1957, 120, 354-360.
9. Klinder K, Skopp G, Mattern R, Aderjan R: The detection of dihydrocodeine and its main metabolites in cases of fatal overdose. Int J Legal Med, 1999, 112, 155-158. (Pubitemid 29197583)
10. Leppert W: Dihydrocodeine as an analgesic for the treatment of moderate to severe chronic pain. Curr Drug Metab, 2010, 11, 494-506.
11. Leppert W: The role of step II opioid analgesics of the World Health Organization analgesic ladder in cancer pain treatment (Polish). Onkol Pol, 2006, 9, 145-148.
12. Leppert W, Majkowicz M: Assessment of analgesia and adverse effects of controlled release tramadol and dihydrocodeine in patients with cancer pain - based on a modified ESAS (Polish). Współcz Onkol, 2008, 12, 246-254.
13. Leppert W, Majkowicz M: The impact of tramadol and dihydrocodeine treatment on quality of life of patients with cancer pain. Int J Clin Pract, 2010, 64, 1681-1687.
14. Leppert W, Mikolajczak P: Analgesic effects and assays of controlled-release tramadol and O-desmethyltramadol in cancer patients with pain. Curr Pharmaceut Biotechnol, 2011, 12, 306-312.
15. Mignat C,Wille U, Ziegler A: Affinity profiles of morphine, codeine and dihydrocodeine and their glucuronides at opioid receptor subtypes. Life Sci, 1995, 56, 793-799.
16. Mikus G, Somogyi AA, Bochner F, Chen ZR: Polymorphic metabolism of opioid narcotic drugs: Possible clinical implications. Ann Acad Med Singapore, 1991, 20, 9-12.
17. Poulsen L, Brøsen K, Arendt-Nielsen L, Gram LF, Elbaek K, Sindrup SH: Codeine and morphine in extensive and poor matabolizers of sparteine: pharmacokinetics, analgesic effect and side effects. Eur J Clin Pharmacol, 1996, 51, 289-295. (Pubitemid 26422976)
18. Robertson JR: Dihydrocodeine: second strand of treatment for drug misusers. Drug Alcohol Rev, 1996, 15, 200-201.
19. Schmidt H, Vormfelde SV, Klinder K, Gundert-Remy U, Gleiter CH, Skopp G, Aderjan R, Fuhr U: Affinities of dihydrocodeine and its metabolites to opioid receptors. Pharmacol Toxicol, 2002, 91, 57-63.
20. Schmidt H, Vormfelde SV, Walchner-Bonjean M, Klinder K, Freudenthaler S, Gleiter CH, Gundert-Remy U et al.: The role of active metabolites in dihydrocodeine effects. Int J Clin Pharmacol Ther, 2003, 41, 95-106. (Pubitemid 36348269)
21. Skopp G, Klinder K, Pötch L, Zimmer G, Lutz R, Aderjan R, Mattern R: Postmortem distribution of dihydrocodeine and metabolites in a fatal case of dihydrocodeine intoxication. Forensic Sci Int, 1998, 95, 99-107. (Pubitemid 28356674)
22. Stamer UM, Lehnen K, Höthker F, Bayerer B, Wolf S, Hoeft A, Stuber F: Impact of CYP2D6 genotype on postoperative tramadol analgesia. Pain, 2003, 105, 231-238. (Pubitemid 37162492)
23. Stamer U, Musshoff F, Kobilay M, Madea B, Hoeft A, Stuber F: Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes. Clin Pharmacol Ther, 2007, 82, 41-47. (Pubitemid 46944194)
24. Webb JA, Rostami-Hodjegan A, Abdul-Manap R, Hofmann U, Mikus G, Kamali F: Contribution of dihydrocodeine and dihydromorphine to analgesia following dihydrocodeine administration in man: a PK-PD modelling analysis. Br J Clin Pharmacol, 2001, 52, 35-43. (Pubitemid 32862767)
25. Wilder-Smith CH, Hill L, Spargo K, Kalla A: Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAID's: a randomized study comparing analgesia, antinociception and gastrointestinal effects. Pain, 2001, 91, 23-31. (Pubitemid 32274172)
26. Wilder-Smith CH, Hufschmid E, Thormann W: The visceral and somatic antinociceptive effects of dihydrocodeine and its metabolite, dihydromorphine. A cross-over study with extensive and quinidine-induced poor matabolizers. Br J Clin Pharmacol, 1998, 45, 575-581. (Pubitemid 28270913)
27. Wordliczek J, Dobrogowski J: Pain treatment (Polish). Wydawnictwo Lekarskie PZWL, Warszawa, 2007.
28. Zelek-Molik A, Taracha E, Nawrat D, Bielawski A, Lehner M, Płaz̈nik A, Nalepa I: Effects of morphine and methadone treatment on mRNA expression of Gα(i) subunits in rat brains. Pharmacol Rep, 2010, 62, 1197-1203.